Executive Summary & Takeaways Quantum technologies are poised to radically alter the technical, political and commercial landscape of the US-Chinese dynamic. As it stands, the US is in a greatly disadvantaged position and current investments do not close the gap in a meaningful timeline. …

I read a recent Atlantic article about the “coming” software pandemic with some surprise — because the pandemic isn’t coming, it’s already here. Bad code has existed as long as there has been code, and we have been suffering the pandemic of bad code at scale for decades. A question…

10 years from now, are we going to look back and realize that banks had already missed the massive market change and were already on the way out? Recently, I’ve been having a number of conversations with friends and clients (all experts) about digital transformation and banks built for the…

I remember grumbling, “Good lord this is a waste of time,” in 1992 while I was working on an AI application for lip-reading. The grumble escaped my lips because I felt like I was spending half my time inputting data cleanly into the video processing neural network. Bouncing from a…

Yesterday morning an interesting dichotomy presented itself — and I’ve been trying to reconcile it. …

I just finished reading this great article in Wired (and speaking of Wired, they’re putting out some great content — definitely recommend) about Illumina sequencer problems discovered by a researcher. …

I have spent many years deeply embedded in the world of cybersecurity, and more broadly working with nations around the world on processes and methods for keeping citizens safe. The instability in the current-day Middle East, combined with recent attacks in California, Colorado, Lebanon & Paris, lead me to one…

To say I am passionate about the potential of genomics is an understatement. That said — I am not blind to the realities and pain points the industry is facing today. …

“Life, with its rules, its obligations, and its freedoms, is like a sonnet: You’re given the form, but you have to write the sonnet yourself.” – Mrs. Whatsit, from Madeleine L’Engle, A Wrinkle in Time IBM’s Watson is good at R&D, and could be good at Clinical R&D, but I…